Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidativestress and metabolic status of ear, nose and throat cancer patients

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 405-414

  Roca Rodriguez M M ^a,b   Garcia Almeida J M ^a   Lupianez Perez Y ^a   Rico, J M ^a   Toledo, M ^a   Alcaide Torres, J ^a   Cardona, F ^a,b   Medina, J A ^a   Tinahones, F J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Inflammation; Metabolic status; N 3 polyunsaturated fatty acids; Oxidative stress; Radiotherapy

Indexed keywords

ALBUMIN; CREATININE; ELECTROLYTE; OMEGA 3 FATTY ACID; PROTEIN; UREA;

ADULT; ARTICLE; BLOOD TOXICITY; BODY MASS; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; EOSINOPHIL; ERYTHROCYTE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEMATOCRIT; HUMAN; INFLAMMATION; MALE; METABOLISM; MUCOSAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; DIETARY FIBER; DIETARY SUPPLEMENTS; EAR NEOPLASMS; ELECTROLYTES; FATTY ACIDS, UNSATURATED; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INTERLEUKIN-6; MALE; MALNUTRITION; MIDDLE AGED; NOSE NEOPLASMS; OXIDATIVE STRESS; PHARYNGEAL NEOPLASMS;

EID: 84891925978     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2806     Document Type: Article

References (53)

1. Koom WS, Ahn SD, Song SY, Lee CG, Moon SH, Chie EK, Jang HS, Oh YT, Lee HS and Keum KC: Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J 30: 132-139, 2012.
2. Righini CA, Timi N, Junet P, Bertolo A, Reyt E and Atallah I: Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 130: 8-14, 2013.
3. Martín-Villares C, San Román-Carbajo J, Fernández-Pello ME, Tapia Risueño M and Domínguez Calvo J: Nutritional status in head and neck cancer patients: the impact on the prognosis. Nutr Hosp 18: 91-94, 2003 (In Spanish).
4. Borek C: Antioxidants and radiation therapy. J Nutr 134: 3207S-3209S, 2004.
5. Michalowski AS: On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs. Acta Oncol 33: 139-157, 1994.
6. Peters LJ: Radiation therapy tolerance limits. For one or for all? - Janeway Lecture. Cancer 77: 2379-2385, 1996.
7. Fridlyand LE and Philipson LH: Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann NY Acad Sci 1066: 136-151, 2005.
8. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
9. Scully C, Epstein J and Sonis S: Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck 25: 1057-1070, 2003.
10. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J and Calais G: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22: 69-76, 2004.
11. Fisher J, Scott C, Scarantino CW, Leveque FG, White RL, Rotman M, Hodson DI, Meredith RF, Foote R, Bachman DG and Lee N: Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09. Int J Radiat Oncol Biol Phys 56: 832-836, 2003.
12. Chencharick JD and Mossman KL: Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 51: 811-815, 1983.
13. Calviello G, Serini S, Piccioni E and Pessina G: Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 61: 287-301, 2009.
14. Ruxton CH, Reed SC, Simpson MJ and Millington KJ: The health benefits of n-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 20: 275-285, 2007.
15. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC and Tisdale MJ: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52: 1479-1486, 2003.
16. Moses AW, Slater C, Preston T, Barber MD and Fearon KC: Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90: 996-1002, 2004.
17. Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G and Baracos V: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21: 129-134, 2003.
18. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M; DGEM (German Society for Nutritional Medicine), Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ, Zander A and ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 25: 245-259, 2006.
19. Jones D: ICRU Report 50 - Prescribing, recording and reporting photon beam therapy. Med Phys 21: 833, 1999.
20. Cox JD, Stetz J and Pajak TF: Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346, 1995.
21. Ali EM and Abdelraheem AG: Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck Oncol 3: 48, 2011.
22. Somani N, Goyal S, Pasricha R, Khuteta N, Agarwal P, Garg AK and Singhal H: Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience. Indian J Med Paediatr Oncol 32: 86-91, 2011.
23. Kubrak C, Olson K, Jha N, Scrimger R, Parliament M, McCargar L, Koski S and Baracos VE: Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view. Head Neck 35: 695-703, 2013.
24. Chen CC, Chen WC, Lu CH, Wang WH, Lin PY, Lee KD and Chen MF: Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys 76: 1214-1224, 2010.
25. Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J and Jabbari MV: Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J 28: 435-440, 2007.
26. Reddy VS, Dakshinamurty KV, Sherke RL and Neela Prasadd T: N-3 Polyunsaturated fatty acids in the prevention of progression of chronic renal disease. Indian J Nephrol 12: 6-9, 2002.
27. Sarsilmaz M, Songur A, Ozyurt H, Kuş I, Ozen OA, Ozyurt B, Söǧüt S and Akyol O: Potential role of dietary ω-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 69: 253-259, 2003.
28. Hauenschild A, Bretzel RG, Schnell-Kretschmer H, Kloer HU, Hardt PD and Ewald N: Successful treatment of severe hypertriglyceridemia with a formula diet rich in n-3 fatty acids and medium-chain triglycerides. Ann Nutr Metab 56: 170-175, 2010.
29. Dhankhar R, Dahiya K, Sharma TK, Ghalaut VS, Atri R and Kaushal V: Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma. Clin Lab 57: 795-798, 2011.
30. Bechoua S, Dubois M, Dominguez Z, Goncalves A, Némoz G, Lagarde M and Prigent AF: Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol 57: 1021-1030, 1999.
31. Machon C, Thezenas S, Dupuy AM, Assenat E, Michel F, Mas E, Senesse P and Cristol JP: Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer 20: 3129-3135, 2012.
32. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY and Huang SF: Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol 36: 147-153, 2011.
33. Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Wu R, Fan YC, Zhong WZ, Wang SL, Zhang XY, Wu LN, Chen XD, Jin XY, Duan QY, Xu R, Chen W, Qian HC and Xiao YP: C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Tumour Biol 33: 891-895, 2012.
34. Peter F, Wittekindt C, Finkensieper M, Kiehntopf M and Guntinas-Lichius O: Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. J Cancer Res Clin Oncol 139: 171-178, 2013.
35. Helzlsouer KJ, Erlinger TP and Platz EA: C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42: 704-707, 2006.
36. Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ and Ghaderi A: Serum interleukin-6 concentration, but not interleukin-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res 17: 7-10, 2011.
37. Yadav A, Kumar B, Datta J, Teknos TN and Kumar P: IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9: 1658-1667, 2011.
38. Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A and Balija M: Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal 17: e10-e15, 2012.
39. De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R and Nuyts S: The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer 5: 42, 2005.
40. Nibali L, Fedele S, D'Aiuto F and Donos N: Interleukin-6 in oral diseases: a review. Oral Dis 18: 236-243, 2012.
41. Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM and Wright J: Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck 34: 985-993, 2012.
42. Salzman R, Pácal L, Kaňková K, Tomandl J, Horáková Z, Tóthová E and Kostřica R: High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma. Int J Clin Oncol 15: 565-570, 2010.
43. Ziech D, Franco R, Pappa A and Panayiotidis MI: Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711: 167-173, 2011.
44. Sharma PK, Dwarakanath BS and Varshney R: Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells. Free Radic Biol Med 53: 1500-1513, 2012.
45. Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D and Mitchell JB: Ionizing radiation-induced oxidative stress alters miRNA expression. PloS One 4: e6377, 2009.
46. Park KS, Lim JW and Kim H: Inhibitory mechanism of n-3 fatty acids in pancreatic inflammation and apoptosis. Ann NY Acad Sci 1171: 421-427, 2009.
47. Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS and Ger LP: Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 33: 1606-1615, 2011.
48. 2-dependent Snail signaling. Free Radic Biol Med 53: 44-50, 2012.
49. Chen B, Rao X, House MG, Nephew KP, Cullen KJ and Guo Z: GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett 309: 37-45, 2011.
50. Korde SD, Basak A, Chaudhary M, Goyal M and Vagga A: Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 80: 382-389, 2011.
51. Dahiya K, Dhankhar R, Madaan H, Singh V and Arora K: Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Ann Clin Lab Sci 42: 94-97, 2012.
52. Mazière C, Conte MA, Degonville J, Ali D and Mazière JC: Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 265: 116-122, 1999.
53. Hafer K, Iwamoto KS and Schiestl RH: Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations. Radiat Res 169: 460-468, 2008.